Alzheimer's Disease

In this 2019 photo provided by Biogen, a researcher works on the development of the medication aducanumab in Cambridge, Mass. On Monday, June 7, 2021, the Food and Drug Administration approved aducanumab, the first new drug for Alzheimer’s disease in nearly 20 years, disregarding warnings from independent advisers that the much-debated treatment hasn’t been shown to help slow the brain-destroying disease. (Biogen via AP)

U.S. approves much-debated Alzheimer’s drug aducanumab panned by experts

Drug from Biogen deemed “reasonably likely” to benefit Alzheimer’s patients


Katie Hogan (right, with hat and sunglasses) was diagnosed with early-onset Alzheimer’s disease in January. The 43-year-old Chilliwack woman is seen here taking part in the Walk for Alzheimer’s with family and friends on the Vedder Rotary Trail on Saturday, May 29, 2021. (Jenna Hauck/ Chilliwack Progress)

Alzheimer’s can strike at young age, says 43-year-old Chilliwack woman with disease

Katie Hogan raising awareness for early-onset Alzheimer’s, brings in more than $6,000 on walk


Talia Yorish, 10, is encouraging Lower Mainland residents to join her in her fundraising efforts for the Alzheimer Society of B.C. She is climbing the Grouse Grind in memory of her grandmother, Mariam, who battled Lewy body dementia before passing away last April. (Contributed photo)

Climb for Alzheimer’s encourages Lower Mainland residents to walk or hike for a cure

North Vancouver 10-year-old taking part in Grouse Grind climb in honour of grandmother

  • Sep 9, 2020